173 related articles for article (PubMed ID: 11770701)
1. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents.
Gladysheva IP; Moroz NA; Karmakova TA; Nemtsova ER; Yakubovskaya RI; Larionova NI
J Drug Target; 2001; 9(5):303-16. PubMed ID: 11770701
[TBL] [Abstract][Full Text] [Related]
2. Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor.
Gladysheva IP; Polekhina OV; Karmakova TA; Nemtsova ER; Yakubovskaya RI; Shen WC; Kennedy AR; Larionova NI
J Control Release; 2001 Jul; 74(1-3):303-8. PubMed ID: 11489510
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops.
Mao Y; Lai C; Vogtentanz G; Schmidt B; Day T; Miller J; Brandon DL; Chen D
Protein J; 2005 Jul; 24(5):275-82. PubMed ID: 16284725
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester.
Larionova NI; Gladysheva IP; Polekhina OV; Kurochkina LP; Gorbatova EN
Appl Biochem Biotechnol; 1996; 61(1-2):139-48. PubMed ID: 9100351
[TBL] [Abstract][Full Text] [Related]
5. Soybean bowman--birk inhibitor conjugates with clinical dextran. synthesis and antiproteolytic activity.
Gladysheva IP; Moroz NA; Papisova AI; Larionova NI
Biochemistry (Mosc); 2001 Apr; 66(4):384-9. PubMed ID: 11403644
[TBL] [Abstract][Full Text] [Related]
6. Disposition of positively charged Bowman-Birk protease inhibitor conjugates in mice: influence of protein conjugate charge density and size on lung targeting.
Ekrami H; Kennedy AR; Shen WC
J Pharm Sci; 1995 Apr; 84(4):456-61. PubMed ID: 7629736
[TBL] [Abstract][Full Text] [Related]
7. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anti-carcinogenic agents.
Persiani S; Yeung A; Shen WC; Kennedy AR
Carcinogenesis; 1991 Jun; 12(6):1149-52. PubMed ID: 2044199
[TBL] [Abstract][Full Text] [Related]
8. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
[TBL] [Abstract][Full Text] [Related]
9. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
Ekrami H; Kennedy AR; Witschi H; Shen WC
J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543
[TBL] [Abstract][Full Text] [Related]
10. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
Clementea A; Domoney C
Curr Protein Pept Sci; 2006 Jun; 7(3):201-16. PubMed ID: 16787260
[TBL] [Abstract][Full Text] [Related]
11. [Conjugation of classic Bowman-Birk soy inhibitor with a copolymer of ethylene oxide and propylene oxide].
Larionova NI; Gladysheva IP; Topchieva IN; Kazanskaia NF
Biokhimiia; 1993 Oct; 58(10):1658-64. PubMed ID: 8268307
[TBL] [Abstract][Full Text] [Related]
12. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
Kennedy AR
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
[TBL] [Abstract][Full Text] [Related]
13. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
Saito T; Sato H; Virgona N; Hagiwara H; Kashiwagi K; Suzuki K; Asano R; Yano T
Cancer Lett; 2007 Aug; 253(2):249-57. PubMed ID: 17343982
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line.
Kyani S; Akrami H; Mostafaei A; Akbari S; Salehi Z
J Cancer Res Ther; 2021; 17(2):504-509. PubMed ID: 34121699
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
[TBL] [Abstract][Full Text] [Related]
16. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
Kennedy AR; Kritchevsky D; Shen WC
Pharm Res; 2003 Dec; 20(12):1908-10. PubMed ID: 14725352
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor.
Wan XS; Koch CJ; Lord EM; Manzone H; Billings PC; Donahue JJ; Odell CS; Miller JH; Schmidt NA; Kennedy AR
J Immunol Methods; 1995 Mar; 180(1):117-30. PubMed ID: 7534802
[TBL] [Abstract][Full Text] [Related]
18. Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.
Billings PC; Brandon DL; Habres JM
Eur J Cancer; 1991; 27(7):903-8. PubMed ID: 1834126
[TBL] [Abstract][Full Text] [Related]
19. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean.
Sadeghalvad M; Mohammadi-Motlagh HR; Karaji AG; Mostafaie A
J Biochem Mol Toxicol; 2019 Dec; 33(12):e22406. PubMed ID: 31593353
[TBL] [Abstract][Full Text] [Related]
20. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
Chen YW; Huang SC; Lin-Shiau SY; Lin JK
Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
